Literature DB >> 212542

Homotransplantation of the liver in a patient with hepatoma and hereditary tyrosinemia.

R O Fisch, E R McCabe, D Doeden, L J Koep, J G Kohlhoff, A Silverman, T E Starzl.   

Abstract

A girl with hereditary tyrosinemia, diagnosed at 6 months of age, was treated with a diet restricted in phenylalanine and tyrosine. At 9 1/2 years of age she developed an acutely enlarged liver and spleen, and the diagnosis of hepatocarcinoma was made. The patient received a liver transplant and tyrosine metabolites became normal while she was receiving a regular diet. Three months later, an infected thrombosis of the portal vein caused her death. Liver transplant appears to be an effective method of enzyme replacement in tyrosinemia and should be considered for prevention of hepatoma.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 212542      PMCID: PMC3022511          DOI: 10.1016/s0022-3476(78)80893-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  21 in total

1.  COMPARATIVE STUDIES OF LIVER AND MUSCLE ALDOLASE. II. IMMUNOCHEMICAL AND CHROMATOGRAPHIC DIFFERENTIATION.

Authors:  R BLOSTEIN; W J RUTTER
Journal:  J Biol Chem       Date:  1963-10       Impact factor: 5.157

Review 2.  A conspectus of research on zinc requirements of man.

Authors:  J A Halsted; J C Smith; M I Irwin
Journal:  J Nutr       Date:  1974-03       Impact factor: 4.798

3.  A micromethod for free erythrocyte porphyrins: the FEP test.

Authors:  S Piomelli
Journal:  J Lab Clin Med       Date:  1973-06

4.  Simple method for determination of urinary -aminolevulinic acid as an index of lead exposure.

Authors:  K Tomokuni; M Ogata
Journal:  Clin Chem       Date:  1972-12       Impact factor: 8.327

5.  Hereditary tyrosinemia and abnormal pyrrole metabolism.

Authors:  E S Kang; P S Gerald
Journal:  J Pediatr       Date:  1970-09       Impact factor: 4.406

6.  The occurrence of hepatoma in the chronic form of hereditary tyrosinemia.

Authors:  A G Weinberg; C E Mize; H G Worthen
Journal:  J Pediatr       Date:  1976-03       Impact factor: 4.406

7.  Dietary treatment in tyrosinemia (tyrosinosis). With a note on the possible recognition of the carrier state.

Authors:  J Gentz; B Lindblad; S Lindstedt; L Levy; W Shasteen; R Zetterstrom
Journal:  Am J Dis Child       Date:  1967-01

8.  Tyrosinemia with acute intermittent porphyria: aminolevulinic acid dehydratase deficiency related to elevated urinary aminolevulinic acid levels.

Authors:  C F Strife; E L Zuroweste; E A Emmett; V N Finelli; H G Petering; H K Berry
Journal:  J Pediatr       Date:  1977-03       Impact factor: 4.406

9.  [Hereditary tyrosinemia and alpha-1-fetoprotein. I. Clinical value of alpha-fetoprotein in hereditary tyrosinemia].

Authors:  L Bélanger; M Bélanger; L Prive; J Larochelle; M Tremblay; G Aubin
Journal:  Pathol Biol (Paris)       Date:  1973-05

10.  On the enzymic defects in hereditary tyrosinemia.

Authors:  B Lindblad; S Lindstedt; G Steen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

View more
  14 in total

1.  Orthotopic Liver Transplantation in Children With Hepatic-Based Metabolic Disease.

Authors:  B J Zitelli; J J Malatack; J C Gartner; B W Shaw; S Iwatsuki; T E Starzl
Journal:  Transplant Proc       Date:  1983-03       Impact factor: 1.066

2.  Renal function in tyrosinaemia type I after liver transplantation: a long-term follow-up.

Authors:  L J W M Pierik; F J van Spronsen; C M A Bijleveld; C M L van Dael
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Liver transplantation in a 23-year-old tyrosinaemia patient: effects on the renal tubular dysfunction.

Authors:  E A Kvittingen; E Jellum; O Stokke; A Flatmark; A Bergan; G Sødal; S Halvorsen; E Schrumpf; E Gjone
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

Review 4.  Changing concepts: liver replacement for hereditary tyrosinemia and hepatoma.

Authors:  T E Starzl; B J Zitelli; B W Shaw; S Iwatsuki; J C Gartner; R D Gordon; J J Malatuck; I J Fox; A H Urbach; D H Van Thiel
Journal:  J Pediatr       Date:  1985-04       Impact factor: 4.406

5.  Auxiliary partial orthotopic liver transplantation for Crigler-Najjar syndrome type I.

Authors:  M Rela; P Muiesan; H Vilca-Melendez; A Dhawan; A Baker; G Mieli-Vergani; N D Heaton
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

Review 6.  Evolution of liver transplantation.

Authors:  T E Starzl; S Iwatsuki; D H Van Thiel; J C Gartner; B J Zitelli; J J Malatack; R R Schade; B W Shaw; T R Hakala; J T Rosenthal; K A Porter
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

7.  Persistent succinylacetone excretion after liver transplantation in a patient with hereditary tyrosinaemia type I.

Authors:  M Tuchman; D K Freese; H L Sharp; C B Whitley; M L Ramnaraine; R A Ulstrom; J S Najarian; N Ascher; N R Buist; A B Terry
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

8.  Fifteen years of clinical liver transplantation.

Authors:  T E Starzl; L J Koep; C G Halgrimson; J Hood; G P Schroter; K A Porter; R Weil
Journal:  Gastroenterology       Date:  1979-08       Impact factor: 22.682

Review 9.  Current strategies for the treatment of hereditary tyrosinemia type I.

Authors:  Merja Ashorn; Sari Pitkänen; Matti K Salo; Markku Heikinheimo
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 10.  Liver transplantation: current concepts.

Authors:  W J Wall
Journal:  CMAJ       Date:  1988-07-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.